PresseMitteilungen CategoriesNewBiotechCategory / Pharmaceuticals & Biotech / Biotech Critical Outcome Technologies Inc. Reports Fiscal 2012 Third Quarter Financial Results LONDON, ONTARIO: ... Horizon Pharma Files Patent Infringement Lawsuit Against Par Pharmaceutical, Inc. for Filing an ANDA Against DUEXIS(R) DEERFIELD, IL: ... MethylGene to Present at the American Association for Cancer Research (AACR) Annual Meeting MONTREAL, QUEBEC: ... Biotonix Announces Fourth Quarter 2011 Results BROSSARD, QUEBEC: ... Warnex Debentures in Default LAVAL, QUEBEC: ... Media Advisory: Theratechnologies to Present at Needham Annual Healthcare Conference MONTREAL, CANADA: ... Warnex to Delay Release of its Financial Statements LAVAL, QUEBEC: ... Daxor Corporation Announces Year End 2011 Earnings NEW YORK, NY: ... Abide Therapeutics and SCYNEXIS Collaborate in Finding Novel Anti-Viral and Anti-Parasitic Agents RESEARCH TRIANGLE PARK, NC: ... IBEX Reports Results for the Six Months Ended January 31, 2012 MONTREAL, QUEBEC: ... Theralase Reports Cancer Therapy Breakthrough TORONTO, ONTARIO: ... Biota Announces Positive Phase IIb Data for Asthmatic Patients With Human Rhinovirus Infection (HRV) MELBOURNE, AUSTRALIA: Oral Treatment for HRV Infection Shows Statistically Significant Reduction of Cold-Like Symptoms ... Cytokinetics to Present at the Eleventh Annual Needham Life Sciences Conference SOUTH SAN FRANCISCO, CA: ... EBI Hosts the 19th Annual Euro-Biotech Partnering Summit in Paris at the Hilton Arc de Triomphe, May 30 - June 1, 2012 BRIDGEWATER, NJ: EBI Invites Executives From Around the Globe to Join Two Keynote Speakers From GlaxoSmithKline and Numerous Other Headliners ... Dynavax Reports Final Phase 3 Data for HEPLISAV(TM) in CKD Patients and New Data From Booster Trial in Hemodialysis Patients BERKELEY, CA: ... AVI BioPharma to Present Company Overview at the 11th Annual Needham Healthcare Conference BOTHELL, WA: Webcast Accessible via AVI Website ... Lorus Therapeutics Announces Positive Results from Its Small Molecule Antimicrobial Program TORONTO, ONTARIO: Potent Antibacterial Activity of LOR-220 Includes Drug-Resistant "Superbugs" ... ISTA Pharmaceuticals Announces Issuance of U.S. Patent for PROLENSA(TM) IRVINE, CA: Patent Term Adjustment Extends Intellectual Property Protection for ISTA's Bromfenac-Based Drug Candidates Through September 2025 ... Pharmaceutical-Biotech Industry Wraps Up Construction on 71 North American Projects in First-Quarter 2012, an Industrial Info News Alert SUGAR LAND, TX: ... Precision BioSciences Files Seventh and Eighth Patent Infringement Lawsuits Against Cellectis, Seeks Permanent Injunction and Monetary Damages RESEARCH TRIANGLE PARK, NC: ... Page 208 von 247: 1 « .. 207 208 209 210 211 212 213 214 215 216 .. » 247